Gaudium IVF IPO 2026 Overview – Price Band, Subscription, Allotment & Market Trends
Latest Grey Market Premium & IPO Details
Gaudium IVF IPO 2026 – Key Info & Highlights
Apply in Gaudium IVF & Women Health IPO 2026 – Get latest price band, lot size, subscription updates, live GMP, key financials, risks, and listing info.
📌 IPO Details
| Company Name | Gaudium IVF IPO |
|---|---|
| Sector / Industry | Hospital |
| IPO Open Date | 20-02-2026 |
| IPO Close Date | 24-02-2026 |
| Allotment Date | 25-02-2026 |
| Refund Date | 25-02-2026 |
| Share Credit Date | 26-02-2026 |
| Listing Date | 27-02-2026 |
| Price Band | ₹75 - ₹79 |
| Lot Size | 189 Shares |
| Min Investment | ₹14931 |
| Net Issue Size | ₹165 Cr |
| Fresh Issue | ₹90 Cr |
| OFS | ₹75 Cr |
| IPO Listing At | BSE NSE |
| DRHP | View DRHP |
| RHP | View RHP |
| Issue Type | Book Build Issue |
| Face Value | ₹5 Per Equity Share |
| Promoter Holding Pre IPO | 99.99 % |
| Promoter Holding Post IPO | 71.30% |
| Min Small HNI Lots | ₹209034 ( 14 lots price) |
| Min Big HNI Lots | ₹10,00,377 ( 67 lots Price ) |
* All Dates are provisional
Quota Allocation
| Category | Allocation (%) |
|---|---|
| Retail Investors | 35.00% |
| QIB (Qualified Institutional Buyers) | 50.00% |
| HNI (High Net Worth Individuals) | 15.00% |
📈 Grey Market Premium (GMP) Day-wise Trend
| GMP Date | GMP Price | Trend | Estimated Listing Price | Estimated Profit* | Last Updated |
|---|---|---|---|---|---|
| 27-02-2026 | ₹0.00 | - | ₹0.00 | ₹0.00 | 27-02-2026 09:46 |
| 26-02-2026 | ₹0.00 | - | ₹0.00 | ₹0.00 | 26-02-2026 23:20 |
| 25-02-2026 | ₹0.00 | - | ₹0.00 | ₹0.00 | 25-02-2026 23:20 |
📝 About Gaudium IVF
Gaudium IVF & Women Health Ltd. is a leading fertility and women’s health company in India, dedicated to providing comprehensive reproductive care with a patient-first approach. Established in 2015, the company has built a network of over 30 specialised centres across the country, including major urban hubs, ensuring accessible and high-quality fertility treatment for patients nationwide.
The company offers a wide range of services including IVF, ICSI, IUI, ovulation induction, fertility preservation, and treatment for reproductive health conditions like PCOD, endometriosis, and male infertility. Gaudium combines advanced laboratory technologies, precise ultrasound-guided procedures, and a team of experienced medical professionals to provide personalized treatment plans aimed at maximizing clinical success while supporting emotional well-being.
With an asset-light operational model, strategic central hubs, and a strong focus on clinical excellence, Gaudium continues to expand its reach, catering to both domestic and international patients. The company’s commitment to innovation, ethical practices, and patient-centered care has made it a trusted name in India’s fertility healthcare sector, helping thousands of families achieve their dream of parenthood.
Gaudium IVF Revised Financials
Profit / Loss & Total Assets (Last 4 Years)
| Financial Year | Revenue (₹ Cr) | Profit / Loss (₹ Cr) | Total Assets (₹ Cr) |
|---|---|---|---|
| FY 2023 | 44.26 | +13.53 | 36.63 |
| FY 2024 | 48.15 | +10.32 | 51.01 |
| FY 2025 (31 Mar) | 70.96 | +19.13 | 88.51 |
| FY 2025 (30 Sep) | 49.75 | +12.51 | 106.62 |
Note: Positive figures indicate profit. Revenue is Total Income; Profit/Loss is Profit After Tax; Total Assets are as reported. All values in ₹ Crore as per latest DRHP / company filings.
Gaudium IVF & Women Health Ltd. Objects of Issue
- Funding Capital Expenditure – ₹50 crore will be used to establish and expand new IVF centres across India, strengthening the company’s pan‑India hub‑and‑spoke network of fertility clinics.
- Debt Repayment / Pre‑payment – ₹20 crore has been allocated to repay or pre‑pay certain existing loans and borrowings, improving the company’s balance sheet health.
- General Corporate Purposes – Remaining funds will be used for overall corporate use including marketing, business development and operational scaling.
- Working Capital Support – A portion of the net proceeds will support day‑to‑day operational needs, helping manage receivables, staffing and clinical resources efficiently.
- Strategic Growth Initiatives – Funds may also be deployed to invest in technology, training programs, and strategic initiatives that enhance the company’s fertility treatment services.
Gaudium IVF & Women Health Ltd. Strengths
- Patient-Centric Care – Focused on providing personalized, high-quality fertility and women’s health services to enhance patient outcomes and experience.
- Experienced Medical Team – A highly skilled team of doctors, embryologists, and nurses with extensive expertise in assisted reproductive technologies.
- Advanced INTEGRA Ti Laboratories – State-of-the-art ICSI labs equipped with precision technology for high success rates and consistent treatment quality.
- Technical Ultrasound-Guided Services – Cutting-edge ultrasound and imaging services ensuring accurate diagnosis and effective treatment planning.
- Strategically Located Central Hubs – Clinics and centres positioned in major urban areas for easier accessibility and operational efficiency.
- Asset-Light Operating Model – Efficient structure minimizing fixed costs while maximizing flexibility and scalability of services across locations.
Gaudium IVF & Women Health Ltd. Risks
- Market Risk – Fluctuations in demand for fertility and women’s health services or macroeconomic changes may affect revenue growth and profitability.
- Regulatory & Compliance Risk – Changes in healthcare regulations, licensing requirements, or government policies could impact operational flexibility and expansion plans.
- Financial Risk – Dependence on borrowings, potential increase in interest rates, or cash flow constraints could affect financial stability and capital allocation.
- Operational Risk – Any disruption in clinic operations, laboratory processes, or supply chain for medical equipment could negatively impact service delivery.
- Competition Risk – Increasing competition from other fertility and women’s health providers could affect market share, pricing power, and patient acquisition.
- Technology & Data Risk – Dependence on sophisticated medical technology and patient data management systems makes the company vulnerable to technical failures or data breaches.
Gaudium IVF & Women Health Ltd.
India’s Leading Fertility & Women’s Health Services Provider
| Founded in: | 2015 |
|---|---|
| MD/CEO: | Dr. Chirag Gandhi |
| Address: | B1/51, Janak Puri East, B‑1, New Delhi – 110058, Delhi, India |
| Website: | www.gaudiumivfcentre.com |
| Phone: | +91 11 4885 8585 |
| Email: | compliance@gaudiumivfcentre.com |
| Services: | IVF (In Vitro Fertilisation), ICSI, IUI, Ovulation Induction, Fertility Counselling, Women’s Health Checkups, Reproductive Surgery, Egg & Sperm Freezing |
IPO Quick Info
20 Feb 2026
24 Feb 2026
Upcoming
Related IPOs
- Bagmane REIT
- Recode Studios
- OnEMI Technology
- Value 360 Communications
- Amba Auto Sales & Services
- Adisoft Technologies
- Leapfrog Engineering
- Citius Transnet InvIT
- Mehul Telecom
- Om Power Transmission
- Propshare Celestia
- Safety Controls
- Emiac Technologies
- Vivid Electromech
- Highness Microelectronics
- Sai Parenterals Limited
- Powerica Limited
- Speciality Medicines
- Tipco Engineering
- Amir Chand Jagdish Kumar